ACRYSOF® IQ RESTOR® SN6AD3Recalls & reported problems
Alcon Laboratories, Inc. · AcrySof(R) ReSTOR(R) APODIZED DIFFRACTIVEASPHERIC SINGLE-PIECE IOL, 13.0mm LENGTH,6.0mm OPTIC, PLANAR HAPTICS. · Class 3 · Implant
All models of ACRYSOF IQ RESTOR (34)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380655101148), received between Sep 17, 2024 and Sep 17, 2024 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Blurred Vision1
- Visual Impairment1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 17, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CONSUMER WHO HAD UNDERGONE INTRAOCULAR LENS (IOL) IMPLANTATION ON 01/16/2008 IN RIGHT EYE, REPORTED THAT HE HAD BEEN EXPERIENCING BLURRED VISION IN RIGHT EYE FOR LAST TWO MONTHS. HE STATED THAT HE HAD SEEN HIS OPHTHALMOLOGIST WHO DID NOT PROVIDE ANY REASON FOR THE BLURRED VISION, BUT TOLD IT WAS TOO RISKY TO REMOVE THE LENS. HE HAD UNDERGONE LASIK PROCEDURE AND YAG (YTTRIUM-ALUMINUM-GARNET LASER) ON (B)(6) 2018. ACCORDING TO THE PATIENT RECORD FROM (B)(6) 2018, ALMOST THREE MONTHS AFTER YAG, HE STATED THAT HE WAS NOT REALLY NOTICING ANY IMPROVEMENT AND WAS STILL SEEING FILM OVER HIS RIGHT EYE. HIS VISION WAS BLURRY AND FUZZY. ACCORDING TO THE PATIENT RECORD FROM (B)(6) 2021, HIS DISTANCE VISION WAS GETTING FOGGY, BUT NEAR VISUAL ACUITY WAS GOOD.
Patient problems: Blurred Vision; Visual Impairment
MAUDE report 20238481 ↗
Other LENS, MULTIFOCAL INTRAOCULAR devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page